Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology, the Society for Endocrinology, the Association...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BMJ Group
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280861/ |
| id |
pubmed-3280861 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-32808612012-02-17 Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) Ramage, John K Ahmed, A Ardill, J Bax, N Breen, D J Caplin, M E Corrie, P Davar, J Davies, A H Lewington, V Meyer, T Newell-Price, J Poston, G Reed, N Rockall, A Steward, W Thakker, R V Toubanakis, C Valle, J Verbeke, C Grossman, A B Guidelines These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology, the Society for Endocrinology, the Association of Surgeons of Great Britain and Ireland (and its Surgical Specialty Associations), the British Society of Gastrointestinal and Abdominal Radiology and others. The authorship represents leaders of the various groups in the UK and Ireland Neuroendocrine Tumour Society, but a large amount of work has been carried out by other specialists, many of whom attended a guidelines conference in May 2009. We have attempted to represent this work in the acknowledgements section. Over the past few years, there have been advances in the management of neuroendocrine tumours, which have included clearer characterisation, more specific and therapeutically relevant diagnosis, and improved treatments. However, there remain few randomised trials in the field and the disease is uncommon, hence all evidence must be considered weak in comparison with other more common cancers. BMJ Group 2011-11-03 2012-01 /pmc/articles/PMC3280861/ /pubmed/22052063 http://dx.doi.org/10.1136/gutjnl-2011-300831 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Ramage, John K Ahmed, A Ardill, J Bax, N Breen, D J Caplin, M E Corrie, P Davar, J Davies, A H Lewington, V Meyer, T Newell-Price, J Poston, G Reed, N Rockall, A Steward, W Thakker, R V Toubanakis, C Valle, J Verbeke, C Grossman, A B |
| spellingShingle |
Ramage, John K Ahmed, A Ardill, J Bax, N Breen, D J Caplin, M E Corrie, P Davar, J Davies, A H Lewington, V Meyer, T Newell-Price, J Poston, G Reed, N Rockall, A Steward, W Thakker, R V Toubanakis, C Valle, J Verbeke, C Grossman, A B Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| author_facet |
Ramage, John K Ahmed, A Ardill, J Bax, N Breen, D J Caplin, M E Corrie, P Davar, J Davies, A H Lewington, V Meyer, T Newell-Price, J Poston, G Reed, N Rockall, A Steward, W Thakker, R V Toubanakis, C Valle, J Verbeke, C Grossman, A B |
| author_sort |
Ramage, John K |
| title |
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| title_short |
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| title_full |
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| title_fullStr |
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| title_full_unstemmed |
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs) |
| title_sort |
guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (nets) |
| description |
These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour Society with endorsement from the clinical committees of the British Society of Gastroenterology, the Society for Endocrinology, the Association of Surgeons of Great Britain and Ireland (and its Surgical Specialty Associations), the British Society of Gastrointestinal and Abdominal Radiology and others. The authorship represents leaders of the various groups in the UK and Ireland Neuroendocrine Tumour Society, but a large amount of work has been carried out by other specialists, many of whom attended a guidelines conference in May 2009. We have attempted to represent this work in the acknowledgements section. Over the past few years, there have been advances in the management of neuroendocrine tumours, which have included clearer characterisation, more specific and therapeutically relevant diagnosis, and improved treatments. However, there remain few randomised trials in the field and the disease is uncommon, hence all evidence must be considered weak in comparison with other more common cancers. |
| publisher |
BMJ Group |
| publishDate |
2011 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280861/ |
| _version_ |
1611506489492504576 |